Salvianolic acid B inhibits thrombosis and directly blocks the thrombin catalytic site
Research and Practice in Thrombosis and Haemostasis · 2024-05 · 8 (4) · 102443
DOI: 10.1016/j.rpth.2024.102443 ↗Kurz gefasst
Fachartikel in der Zeitschrift Research and Practice in Thrombosis and Haemostasis, 2024-05. Verfasst von Miguel A D Neves und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Canadian Blood Services, CIHR.
Abstract (Originalsprache)
Background
Salvianolic acid B (SAB) is a major component of Salvia miltiorrhiza root (Danshen), widely used in East/Southeast Asia for centuries to treat cardiovascular diseases. Danshen depside salt, 85% of which is made up of SAB, is approved in China to treat chronic angina. Although clinical observations suggest that Danshen extracts inhibited arterial and venous thrombosis, the exact mechanism has not been adequately elucidated.
Objective
To delineate the antithrombotic mechanisms of SAB.
Methods
We applied platelet aggregation and coagulation assays, perfusion chambers, and intravital microscopy models. The inhibition kinetics and binding affinity of SAB to thrombin are measured by thrombin enzymatic assays, intrinsic fluorescence spectrophotometry, and isothermal titration calorimetry. We used molecular in silico docking models to predict the interactions of SAB with thrombin.
Results
SAB dose-dependently inhibited platelet activation and aggregation induced by thrombin. SAB also reduced platelet aggregation induced by adenosine diphosphate and collagen. SAB attenuated blood coagulation by modifying fibrin network structures and significantly decreased thrombus formation in mouse cremaster arterioles and perfusion chambers. The direct SAB-thrombin interaction was confirmed by enzymatic assays, intrinsic fluorescence spectrophotometry, and isothermal titration calorimetry. Interestingly, SAB shares key structural similarities with the trisubstituted benzimidazole class of thrombin inhibitors, such as dabigatran. Molecular docking models predicted the binding of SAB to the thrombin active site.
Conclusion
Our data established SAB as the first herb-derived direct thrombin catalytic site inhibitor, suppressing thrombosis through both thrombin-dependent and thrombin-independent pathways. Purified SAB may be a cost-effective agent for treating arterial and deep vein thrombosis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
- Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Toronto, Ontario, Canada.
- Toronto Platelet Immunobiology Group, University of Toronto, Toronto, Ontario, Canada.
- Canadian Blood Services Centre for Innovation, Toronto, Ontario, Canada.
- Department of Physiology, University of Toronto, Toronto, Ontario, Canada.
- Department of Chemistry and Centre for Research on Biomolecular Interactions, York University, Toronto, Ontario, Canada.
Förderung
- Canadian Blood Services
- CIHR
Zitieren
APA
Neves, M. A. D., Ni, T. T., Mackeigan, D. T., Shoara, A. A., Lei, X., Slavkovic, S., Yu, S. Y., Stratton, T. W., Gallant, R. C., Zhang, D., Xu, X. R., Fernandes, C., Zhu, G., Hu, X., Chazot, N., Donaldson, L. W., Johnson, P. E., Connelly, K., Rand, M., …, & Ni, H. (2024). Salvianolic acid B inhibits thrombosis and directly blocks the thrombin catalytic site. Research and Practice in Thrombosis and Haemostasis, 8(4), 102443. https://doi.org/10.1016/j.rpth.2024.102443
Vancouver
Neves MAD, Ni TT, Mackeigan DT, Shoara AA, Lei X, Slavkovic S, et al. Salvianolic acid B inhibits thrombosis and directly blocks the thrombin catalytic site. Research and Practice in Thrombosis and Haemostasis. 2024;8(4):102443. doi:10.1016/j.rpth.2024.102443
BibTeX
@article{Neves2024,
author = {Neves, Miguel A D and Ni, Tiffany T and Mackeigan, Daniel T and Shoara, Aron A and Lei, Xi and Slavkovic, Sladjana and Yu, Si-Yang and Stratton, Tyler W and Gallant, Reid C and Zhang, Dan and Xu, Xiaohong Ruby and Fernandes, Cheryl and Zhu, Guangheng and Hu, Xudong and Chazot, Noa and Donaldson, Logan W and Johnson, Philip E and Connelly, Kim and Rand, Margaret and Wang, Yiming and Ni, Heyu},
title = {Salvianolic acid B inhibits thrombosis and directly blocks the thrombin catalytic site},
journal = {Research and Practice in Thrombosis and Haemostasis},
year = {2024},
volume = {8},
number = {4},
pages = {102443},
doi = {10.1016/j.rpth.2024.102443}
}
EUVIMED